William Hildebrand to Mammary Neoplasms, Experimental
This is a "connection" page, showing publications William Hildebrand has written about Mammary Neoplasms, Experimental.
Connection Strength
0.328
-
Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival. Theranostics. 2022; 12(2):639-656.
Score: 0.185
-
NetH2pan: A Computational Tool to Guide MHC Peptide Prediction on Murine Tumors. Cancer Immunol Res. 2018 06; 6(6):636-644.
Score: 0.143